Serum-free medium and mesenchymal stromal cells enhance functionality and stabilize integrity of rat hepatocyte spheroids

Cell Transplantation

Volumn 22, Issue 2, 2013, Pages 299-308

  Bao, Ji ^a,b   Fisher, James E ^b   Lillegard, Joseph B ^b   Wang, William ^b   Amiot, Bruce ^c   Yu, Yue ^b   Dietz, Allan B ^b   Nahmias, Yaakov ^d   Nyberg, Scott L ^b  

^a SICHUAN UNIVERSITY   (China)

^b MAYO CLINIC   (United States)

^c Brami Biomedical Inc   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bioartificial liver; Hepatocyte; Medium; Spheroid; Ureagenesis

Indexed keywords

UREA;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DETOXIFICATION; GENE EXPRESSION; LIVER CELL; LIVER FUNCTION; MALE; MESENCHYMAL STROMA CELL; MICROENVIRONMENT; MULTICELLULAR SPHEROID; NONHUMAN; PRIORITY JOURNAL; PROTEIN DIET; RAT; SUSPENSION CELL CULTURE; UREA CYCLE;

ANIMALS; CULTURE MEDIA, SERUM-FREE; DISEASE MODELS, ANIMAL; HEPATOCYTES; LIVER, ARTIFICIAL; MALE; MESENCHYMAL STROMAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; SPHEROIDS, CELLULAR;

EID: 84874376590     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X656054     Document Type: Article

References (27)

1. Abu-Absi, S.; Friend, J.; Hansen, L.; Hu, W.-S. Structural polarity and functional bile canaliculi in rat hepatocytes spheroids. Exp. Cell Res. 274:56-67; 2002.
2. Brophy, C. M.; Luebke-Wheeler, J. L.; Amiot, B. P.; Khan, H.; Remmel, R. P.; Rinaldo, P.; Nyberg, S. L. Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function. Hepatology 49:578-586; 2009.
3. Chong, T. W.; Smith, R. L.; Hughes, M. G.; Camden, J.; Rudy, C. K.; Evans, H. L.; Sawyer, R. G.; Pruett, T. L. Primary human hepatocytes in spheroid formation to study hepatitis C infection. J. Surg. Res. 130:52-57; 2006.
4. Chua, K.; Lim, W.; Zhang, P. Stable immobilization of rat hepatocyte spheroids on galactosylated nanofiber scaffold. Biomaterials 26:2537-2547; 2005.
5. Clemmesen, J.; Larsen, F.; Kondrug, J.; Hansen, B.; Ott, P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29:648-653; 1999.
6. Demetriou, A. A.; Brown, Jr., R. S.; Busuttil, R. W.; Fair, J.; McGuire, B. M.; Rosenthal, P.; Am Esch 2nd, J. S.; Lerut, J.; Nyberg, S. L.; Salizzoni, M.; Fagan, E. A.; de Hemptinne, B.; Broelsch, C. E.; Muraca, M.; Salmeron, J. M.; Rabkin, J. M.; Metselaar, H. J.; Pratt, D.; De La Mata, M.; McChesney, L. P.; Everson, G. T.; Lavin, P. T.; Stevens, A. C.; Pitkin, Z.; Solomon, B. A. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann. Surg. 239:660-667; 2004.
7. Denis, J.; Delorme, M. L.; Boschat, M.; Nordlinger, B.; Opolon, P. Respective roles of ammonia, amino acids, and medium-sized molecules in the pathogenesis of experimentally induced acute hepatic encephalopathy. J. Neurochem. 40:10-19; 1983.
8. Glicklis, R.; Merchuk, J. C.; Cohen, S. Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions. Biotechnol. Bioeng. 86:672-680; 2004.
9. Haussinger, D.; Lamers, W.; Moorman, A. Hepatocyte heterogeneity in the metabolism of amino acids and ammonia. Enzyme 46:72-93; 1992.
10. Hewitt, W.; Chen, S.; Watanabe, W.; Arnaout, W.; Shackleton, C.; Rozga, J.; Demetriou,A. Treatment of acute hepatic failure with porcine hepatocyte-based bioartificial liver (BAL). Hepatology 24:436A; 1996.
11. Kidambi, S.; Yarmush, R. S.; Novik, E.; Chao, P.; Yarmush, M. L.; Nahmias, Y. Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance. Proc. Natl. Acad. Sci. USA 106:15714-15719; 2009.
12. Lillegard, J. B.; Fisher, J. E.; Nedredal, G.; Luebke- Wheeler, J.; Bao, J.; Wang, W.; Amoit, B.; Nyberg, S. L. Normal atmospheric oxygen tension and the use of antioxidants improve hepatocyte spheroid viability and function. J. Cell. Physiol. 226:2987-2996; 2011.
13. Lu, H. F.; Chua, K. N.; Zhang, P. C.; Lim, W. S.; Ramakrishna, S.; Leong, K. W.; Mao, H. Q. Threedimensional coculture of rat hepatocyte spheroids and NIH/3T3 fibroblasts enhances hepatocyte functional maintenance. Acta Biomater. 1:399-410; 2005.
14. McIntosh, M.; Corner, S.; Amiot, B.; Nyberg, S. Engineering analysis and development of the spheroid reservoir bioartificial liver. IEEE Eng. Med. Biol. Soc. 2009:5985-5988; 2009.
15. Millis, J.; Losanoff, J. Technology insight: Liver support systems. Nat. Clin. Pract. Gastroenterol. Hepatol. 2:398-405; 2005.
16. Millis, J. M.; Cronin, D. C.; Johnson, R.; Conjeevaram, H.; Conlin, C.; Trevino, S.; Maguire, P. Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: System modifications and clinical impact. Transplantation 74:1735-1746; 2002.
17. Morris, Jr., S. M.; Moncman, C. L.; Rand, K. D.; Dizikes, G. J.; Cederbaum, S. D.; O'Brien, W. E. Regulation of mRNA levels for five urea cycle enzymes in rat liver by diet, cyclic AMP, and glucocorticoids. Arch. Biochem. Biophys. 256:343-353; 1987.
18. Nakazawa, K.; Lee, S. W.; Fukuda, J.; Yang, D. H.; Kunitake, T. Hepatocyte spheroid formation on a titanium dioxide gel surface and hepatocyte long-term culture. J. Mater. Sci. Mater. Med. 17:359-364; 2006.
19. Nedredal, G. I.; Elvevold, K.; Ytrebo, L. M.; Fuskevag, O. M.; Pettersen, I.; Bertheussen, K.; Langbakk, B.; Smedsrod, B.; Revhaug, A. Significant contribution of liver nonparenchymal cells to metabolism of ammonia and lactate and cocultivation augments the functions of a bioartificial liver. Am. J. Physiol. Gastrointest. Liver Physiol. 293:G75-G83; 2007.
20. Nyberg, S. L.; Hardin, J.; Amiot, B.; Argikar, U. A.; Remmel, R. P.; Rinaldo, P. Rapid, large-scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver. Liver Transplant. 11:901-910; 2005.
21. Peshwa, M.; Wu, F.; Follstad, B.; Cerra, F.; Hu, W.-S. Kinetics of hepatocyte spheroid formation. Biotechnol. Prog. 10:460-466; 1994.
22. Rinaldo, P.; Hahn, S.; Matern, D. Inborn errors of amino acid, organic acid, and fatty acid metabolism. In: Burtis, C.; Ashwood, E.; Bruns, D., Eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. St. Louis, MO: Elsevier Saunders; 2005:2207-2247.
23. Seglen, P. Preparation of isolated rat liver cells. Methods Cell Biol. 13:29-83; 1976.
24. Shi, M.; Liu, Z.W.; Wang, F.S. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin. Exp. Immunol. 164:1-8; 2011.
25. Snodgrass, P.; Lin, R.; Muller, W.; Aoki, T. Induction of urea cycle enzymes of rat liver by glucagon. J. Biol. Chem. 253:2748-2753; 1978.
26. Tsiaoussis, J.; Newsome, P.; Nelson, L.; Hayes, P.; Plevris, J. Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transplant. 7:2-10; 2001.
27. Ytrebo, L. M.; Kristiansen, R. G.; Maehre, H.; Fuskevag, O. M.; Kalstad, T.; Revhaug, A.; Cobos, M. J.; Jalan, R.; Rose, C. F. L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure. Hepatology 50:165-174; 2009.